New York, NY -- (SBWIRE) -- 12/27/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Progenics Pharmaceuticals, Inc (NASDAQ:PGNX), Graphic Packaging Holding Company (NYSE:GPK), Brigus Gold Corp (USA) (NYSEMKT:BRD), Synergy Pharmaceuticals Inc (NASDAQ:SGYP)
Progenics Pharmaceuticals, Inc (NASDAQ:PGNX) showed a volume of 1.05 million shares by the end of last trade whereas the average volume of the stock remained 806,743.00 shares. The stock opened the session at $5.53 but then moved to $5.69. At that price, the stock showed a positive performance of 4.21%. Progenics Pharmaceuticals, Inc. (Progenics) is a biopharmaceutical company focuses on research and development for biotechnology product candidates in oncology, virology, supportive care and gastroenterology. It is also engaged in research to identify multiplex phosphoinositide 3-kinase inhibitors for blocking signaling pathways in the growth of aggressive cancers. In gastroenterology, its first commercial product is RELISTOR subcutaneous injection. Its principal product candidate is PSMA ADC, a fully human monoclonal antibody-drug conjugate directed against prostate specific membrane antigen,
Will PGNX Continue To Move Higher? Find Out Here
Graphic Packaging Holding Company (NYSE:GPK) opened the session at $9.44 and closed the session at $9.49. The stock showed a positive of 0.53% in previous trading session. Graphic Packaging Holding Company (GPHC) is a provider of packaging solutions for a variety of products to food, beverage and other consumer products companies. It is also a producer of folding cartons and coated unbleached kraft paperboard, coated-recycled board and multi-wall bags. The Company operates in two business segments: paperboard packaging and flexible packaging. The Company’s customers include beverage, food and other consumer products industries.
For How Long GPK will fight for Profitability? Read This Trend Analysis report
Brigus Gold Corp (USA) (NYSEMKT:BRD) opened the session at $0.76 and closed the session at $0.794. The stock showed a positive performance of 2.83% in previous trading session. The beta of the stock remained 0.99. Brigus Gold Corp. (Brigus) is a mining company. The Company is engaged in the extraction, processing, and refining of gold deposits, as well as related activities, including the acquisition, exploration and development of mineral properties principally located in North America. Its sole mining operation is the Black Fox Mine. As of December 31, 2011, the Company was evaluating the Goldfields Project, which hosts the Box and Athona gold deposits.
Why Should Investors Buy BRD After The Recent Gain? Just Go Here and Find Out
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) the stock advanced 7.23% and finished the session at $5.19. Traded with volume of 1.03 million shares in the prior session and the average volume of the stock remained 428,389.00 shares. The beta of the stock remained -0.36. Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. The Company’s lead product candidate is plecanatide, a guanylyl cyclase C (GC-C), receptor agonist, to treat GI disorders, primarily chronic constipation (CC), and constipation-predominant-irritable bowel syndrome (IBS-C). It is also developing SP-333, the second generation GC-C receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis (UC).
Will SGYP Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)